Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Center for Research Resources (NCRR)
With
National Institute of Neurological Disorders and Stroke (NINDS)
University of Rochester
PROTOCOL OUTLINE: This is a randomized, double-blind study. Patients are randomly assigned to prednisone or placebo. Therapy is administered daily for 12 weeks; prednisone is then tapered.
Age
5–15
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
PROTOCOL ENTRY CRITERIA:
Ambulatory males with Duchenne muscular dystrophy
No medical/psychiatric contraindication to protocol therapy
No requirement for regular use of prescription medication